Bendroflumethiazide

Страна: Нова Зеландия

Език: английски

Източник: Medsafe (Medicines Safety Authority)

Активна съставка:

Bendroflumethiazide 2.5mg;  ;  

Предлага се от:

Ipca Pharma (NZ) Pty Limited

INN (Международно Name):

Bendroflumethiazide 2.5 mg

дозиране:

2.5 mg

Лекарствена форма:

Tablet

Композиция:

Active: Bendroflumethiazide 2.5mg     Excipient: Lactose Purified talc Starch Stearic acid

Броя в опаковка:

Blister pack, PVC/PVDC, 14 tablets

Клас:

Prescription

Вид предписание :

Prescription

Произведено от:

Ipca Laboratories Limited

Терапевтични показания:

Bendrofluazide is indicated in the treatment of oedema associated with conditions such as: congestive heart failure, nephrotic syndrome and cirrhosis of the liver.

Каталог на резюме:

Package - Contents - Shelf Life: Blister pack, PVC/PVDC - 14 tablets - 24 months from date of manufacture stored at or below 25°C - Blister pack, PVC/PVDC - 28 tablets - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE - 500 tablets - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE - 1000 tablets - 24 months from date of manufacture stored at or below 25°C

Дата Оторизация:

2006-06-28